YY1: A Master Regulator at the Crossroads of Targeted Cancer Therapy - A Commentary
Our recent publication entitled “YY1 downregulation underlies therapeutic response to molecular targeted agents” represents a significant advancement in our understanding of the molecular mechanisms governing drug resistance in oncogene-addicted cancers [1].
Authors
- Junhong Jiang
Publication Details
- Journal
- Addiction & Addictive Disorders
- Published
- 2025-08-18
- DOI
- https://doi.org/10.24966/aad-7276/100199
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00